Back
Stoke Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
STOK
Stoke Therapeutics, Inc.
Last Price:
$32.17
Seasonality Move:
-13.44%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STOK is experiencing slight selling pressure.
Stoke Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.61 | Sell |
| 20-day SMA: | 31.94 | Buy |
| 50-day SMA: | 30.25 | Buy |
| 200-day SMA: | 17.97 | Buy |
| 8-day EMA: | 25.18 | Buy |
| 20-day EMA: | 14.61 | Buy |
| 50-day EMA: | 6.91 | Buy |
| 200-day EMA: | 1.89 | Buy |
Stoke Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.51 | Buy |
| Relative Strength Index (14 RSI): | 53.63 | Buy |
| Chaikin Money Flow: | -36602 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.79 - 32.99) | Buy |
| Bollinger Bands (100): | (19.93 - 31.93) | Buy |
Stoke Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Stoke Therapeutics, Inc. Stock
Is Stoke Therapeutics, Inc. Stock a Buy?
-
Stoke Therapeutics, Inc. share price is 32.17 while STOK 8-day simple moving average is 32.61, which is a Sell signal.
-
The stock price of STOK is 32.17 while Stoke Therapeutics, Inc. 20-day SMA is 31.94, which makes it a Buy.
-
Stoke Therapeutics, Inc. 50-day simple moving average is 30.25 while STOK share price is 32.17, making it a Buy technically.
-
STOK stock price is 32.17 and Stoke Therapeutics, Inc. 200-day simple moving average is 17.97, creating a Buy signal.
STOK Technical Analysis vs Fundamental Analysis
Sell
50
Stoke Therapeutics, Inc. (STOK)
is a Sell
Is Stoke Therapeutics, Inc. a Buy or a Sell?
-
Stoke Therapeutics, Inc. stock is rated a SellThe current Stoke Therapeutics, Inc. [STOK] share price is $32.17. The Score for STOK is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Stoke Therapeutics, Inc. Stock Info
Market Cap:
1.8B
Price in USD:
32.17
Share Volume:
292.8K
Stoke Therapeutics, Inc. 52-Week Range
52-Week High:
38.69
52-Week Low:
5.35
Sell
50
Stoke Therapeutics, Inc. (STOK)
is a Sell
Stoke Therapeutics, Inc. Share Price Forecast
-
What is the Stoke Therapeutics, Inc. stock price today?The Stoke Therapeutics, Inc. stock price is 32.17 USD today.
-
Will STOK stock go up or go down?Stoke Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Stoke Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Stoke Therapeutics, Inc. is overvalued.
Is Stoke Therapeutics, Inc. Stock a Buy?
-
Stoke Therapeutics, Inc. share price is 32.17 while STOK 8-day exponential moving average is 25.18, which is a Buy signal.
-
The stock price of STOK is 32.17 while Stoke Therapeutics, Inc. 20-day EMA is 14.61, which makes it a Buy.
-
Stoke Therapeutics, Inc. 50-day exponential moving average is 6.91 while STOK share price is 32.17, making it a Buy technically.
-
STOK stock price is 32.17 and Stoke Therapeutics, Inc. 200-day simple moving average is 1.89, creating a Buy signal.
Fundamental Analysis of Stoke Therapeutics, Inc.
Is Stoke Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.07 per share, and a decrease next year of $3.13 per share.
Technical Analysis of Stoke Therapeutics, Inc.
Should I short Stoke Therapeutics, Inc. stock?
-
STOK Moving Average Covergence Divergence (MACD) indicator is 8.51, suggesting Stoke Therapeutics, Inc. is a Buy
-
Stoke Therapeutics, Inc. Relative Strength Index (RSI) is 53.63, which suggest Stoke Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Stoke Therapeutics, Inc. is (29.79 - 32.99), which suggest Stoke Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Stoke Therapeutics, Inc. is (19.93 - 31.93), which suggest Stoke Therapeutics, Inc. is a Buy
* Stoke Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.